Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Datz

Showing results (101-110 of 171) with videos related to

Pageof 18
Sort By:
Journal of Hepatology|May 29, 2012
Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis CAlbert Friedrich Stättermayer, Karoline Rutter, Sandra Beinhardt, et al.
Cell Cycle (Georgetown, Tex.)|July 4, 2012
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancersFerenc G Rick, Stefan Buchholz, Andrew V Schally, et al.
Journal of Clinical Medicine|November 30, 2018
Association between Cardiovascular Risk and Diabetes with Colorectal Neoplasia: A Site-Specific AnalysisDavid Niederseer, Isabelle Bracher, Andreas Stadlmayr, et al.
Rheumatology International|October 6, 2025
Rheumatoid arthritis is independently associated with metabolic Dysfunction-Associated steatotic liver disease: evidence from the paracelsus 10,000 Population-Based cohort studyMathias Ausserwinkler, Axel J Hueber, Sophie Gensluckner, et al.
The Journal of Clinical Endocrinology and Metabolism|May 13, 2021
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Rather a Bystander Than a Driver of MortalityGeorg Semmler, Sarah Wernly, Sebastian Bachmayer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 1, 2013
Long-term outcomes of patients with Wilson disease in a large Austrian cohortSandra Beinhardt, Waltraud Leiss, Albert Friedrich Stättermayer, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2006
Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxelFlorian Hohla, Andrew V Schally, Karoly Szepeshazi, et al.
Journal of Hepatology|December 13, 2005
Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infectionPeter Ferenci, Elisabeth Formann, Hermann Laferl, et al.
Hepatology International|October 1, 2025
Association between depression and metabolic dysfunction-associated steatotic liver disease: a cross-sectional analysis from the paracelsus 10,000 StudyFlorian Koutny, Vanessa Frey, Christian Datz, et al.
Plos One|November 15, 2018
HFE hemochromatosis screening in patients with severe hip osteoarthritis: A prospective cross-sectional studyBastian Oppl, Emma Husar-Memmer, Svea Pfefferkorn, et al.
Pageof 18

Showing results (101-110 of 171) with videos related to

Sort By:
Pageof 18
Journal of Hepatology|May 29, 2012
Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis CAlbert Friedrich Stättermayer, Karoline Rutter, Sandra Beinhardt, et al.
Cell Cycle (Georgetown, Tex.)|July 4, 2012
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancersFerenc G Rick, Stefan Buchholz, Andrew V Schally, et al.
Journal of Clinical Medicine|November 30, 2018
Association between Cardiovascular Risk and Diabetes with Colorectal Neoplasia: A Site-Specific AnalysisDavid Niederseer, Isabelle Bracher, Andreas Stadlmayr, et al.
Rheumatology International|October 6, 2025
Rheumatoid arthritis is independently associated with metabolic Dysfunction-Associated steatotic liver disease: evidence from the paracelsus 10,000 Population-Based cohort studyMathias Ausserwinkler, Axel J Hueber, Sophie Gensluckner, et al.
The Journal of Clinical Endocrinology and Metabolism|May 13, 2021
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Rather a Bystander Than a Driver of MortalityGeorg Semmler, Sarah Wernly, Sebastian Bachmayer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 1, 2013
Long-term outcomes of patients with Wilson disease in a large Austrian cohortSandra Beinhardt, Waltraud Leiss, Albert Friedrich Stättermayer, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2006
Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxelFlorian Hohla, Andrew V Schally, Karoly Szepeshazi, et al.
Journal of Hepatology|December 13, 2005
Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infectionPeter Ferenci, Elisabeth Formann, Hermann Laferl, et al.
Hepatology International|October 1, 2025
Association between depression and metabolic dysfunction-associated steatotic liver disease: a cross-sectional analysis from the paracelsus 10,000 StudyFlorian Koutny, Vanessa Frey, Christian Datz, et al.
Plos One|November 15, 2018
HFE hemochromatosis screening in patients with severe hip osteoarthritis: A prospective cross-sectional studyBastian Oppl, Emma Husar-Memmer, Svea Pfefferkorn, et al.
Pageof 18